Viking Therapeutics (VKTX) Tops Q1 EPS by 2c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.26), $0.02 better than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Viking Therapeutic (VKTX) PT Raised to $87 at Truist Securities
• Viking Therapeutics reports VK2735 weight maintenance data with less frequent dosing
• B.Riley: 'We are aggressive buyers of Viking Therapeutics'